首页> 外文期刊>International Journal of Molecular Sciences >Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens
【24h】

Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens

机译:术前分子分析可部分克服不确定性甲状腺结节的细针穿刺(FNA)的诊断局限性:评估BRAF和RAS野生型例行风干FNA标本中的RET / PTC1重排

获取原文
           

摘要

Molecular markers are helpful diagnostic tools, particularly for cytologically indeterminate thyroid nodules. Preoperative RET/PTC1 rearrangement analysis in BRAF and RAS wild-type indeterminate thyroid nodules would permit the formulation of an unambiguous surgical plan. Cycle threshold values according to the cell count for detection of the RET/PTC1 rearrangement by real-time reverse transcription-polymerase chain reaction (RT-PCR) using fresh and routine air-dried TPC1 cells were evaluated. The correlation of RET/PTC1 rearrangement between fine-needle aspiration (FNA) and paired formalin-fixed paraffin-embedded (FFPE) specimens was analyzed. RET/PTC1 rearrangements of 76 resected BRAF and RAS wild-type classical PTCs were also analyzed. Results of RT-PCR and the Nanostring were compared. When 100 fresh and air-dried TPC1 cells were used, expression of RET/PTC1 rearrangement was detectable after 35 and 33 PCR cycles, respectively. The results of RET/PTC1 rearrangement in 10 FNA and paired FFPE papillary thyroid carcinoma (PTC) specimens showed complete correlation. Twenty-nine (38.2%) of 76 BRAF and RAS wild-type classical PTCs had RET/PTC1 rearrangement. Comparison of RET/PTC1 rearrangement analysis between RT-PCR and the Nanostring showed moderate agreement with a κ value of 0.56 ( p = 0.002). The RET/PTC1 rearrangement analysis by RT-PCR using routine air-dried FNA specimen was confirmed to be technically applicable. A significant proportion (38.2%) of the BRAF and RAS wild-type PTCs harbored RET/PTC1 rearrangements.
机译:分子标记是有用的诊断工具,尤其是对于细胞学上不确定的甲状腺结节。在BRAF和RAS野生型不确定的甲状腺结节中进行术前RET / PTC1重排分析将允许制定明确的手术计划。评估了根据细胞计数的循环阈值,以使用新鲜和常规的风干TPC1细胞通过实时逆转录聚合酶链反应(RT-PCR)检测RET / PTC1重排。分析了细针抽吸(FNA)和成对的福尔马林固定石蜡包埋(FFPE)标本之间RET / PTC1重排的相关性。还分析了76个切除的BRAF和RAS野生型经典PTC的RET / PTC1重排。比较了RT-PCR和Nanostring的结果。当使用100个新鲜和风干的TPC1细胞时,分别在35和33个PCR循环后可检测到RET / PTC1重排的表达。 RET / PTC1重排在10个FNA和成对的FFPE乳头状甲状腺癌(PTC)标本中的结果显示出完全相关。 76例BRAF和RAS野生型经典PTC中有29例(38.2%)具有RET / PTC1重排。 RT-PCR和Nanostring之间的RET / PTC1重排分析比较显示,κ值为0.56(p = 0.002),具有中等一致性。使用常规的风干FNA样品通过RT-PCR进行的RET / PTC1重排分析已被证实在技术上适用。大部分(38.2%)的BRAF和RAS野生型PTC具有RET / PTC1重排。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号